Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group-Reference-Cited by-同舟云学术

Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group

Published:2015-12 Issue:12 Volume:15 Page:715-727
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Sirhan Shireen,Busque Lambert,Foltz Lynda,Grewal Kuljit,Hamm Caroline,Laferriere Nicole,Laneuville Pierre,Leber Brian,Liew Elena,Olney Harold J.,Prchal Jaroslav,Porwit Anna,Gupta Vikas

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference90 articles.

1. Some speculations on the myeloproliferative syndromes;Dameshek;Blood,1951

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera;James;Nature,2005

3. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis;Scott;N Engl J Med,2007

4. How common are myeloproliferative neoplasms? A systematic review and meta-analysis;Titmarsh;Am J Hematol,2014

5. Epidemiology of myeloproliferative neoplasms in the United States;Mehta;Leuk Lymphoma,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in polycythemia vera and lessons for acute leukemia;Best Practice & Research Clinical Haematology;2021-12

2. Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy;Pharmaceuticals;2021-06-24

3. Current management strategies for polycythemia vera and essential thrombocythemia;Blood Reviews;2020-07

4. Management of Polycythemia Vera: A Survey of Canadian Physician Practice Patterns;Clinical Lymphoma Myeloma and Leukemia;2019-01

5. Policitemia vera: presentación clínica, diagnóstico y nuevos abordajes terapéuticos.;Archivos de Medicina (Manizales);2018-11-19